Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study

BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is a standard therapy strategy for most malignant disorders in children. However, transplant-related pneumonia remains a major therapy challenge and mesenchymal stromal cells (MSCs) are rarely reported in HSCT-related pneumonia. The aim of o...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yuhua, Yang, Xu, Zhang, Xiaohong, Liu, Shanshan, Liu, Xiaoping, Liu, Xiaodan, Luo, Ailing, Cai, Mansi, Yan, Yaping, Xu, Ling, Jiang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241242/
https://www.ncbi.nlm.nih.gov/pubmed/35765041
http://dx.doi.org/10.1186/s13287-022-02960-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241242/
https://www.ncbi.nlm.nih.gov/pubmed/35765041
http://dx.doi.org/10.1186/s13287-022-02960-7

Ejemplares similares